| scholarly article | Q13442814 |
| P50 | author | Susan M. Ramin | Q110252023 |
| P2093 | author name string | Yang Xia | |
| M John Hicks | |||
| Rodney E Kellems | |||
| Yingbo Dai | |||
| Roxanna A Irani | |||
| Sean C Blackwell | |||
| Cissy Chenyi Zhou | |||
| P2860 | cites work | Endothelin 1 and angiotensin II in preeeclampsia | Q28306251 |
| Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. | Q30481575 | ||
| The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
| Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia | Q33748650 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Fetal nutrition and adult disease | Q33900856 | ||
| Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
| Endothelin, hypertension and chronic kidney disease: new insights | Q34028803 | ||
| Antiandrogens in the treatment of priapism | Q34109819 | ||
| Fetal programming and adult health | Q34421315 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
| Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia | Q34707068 | ||
| Trophoblast deportation and the maternal inflammatory response in pre-eclampsia | Q35190881 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice | Q63379057 | ||
| Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia | Q67956897 | ||
| Maternal plasma level of endothelin is increased in preeclampsia | Q67973452 | ||
| Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment | Q68053902 | ||
| Endothelial cell activation by tumour necrosis factor-alpha (TNF-α and the development of pre-eclampsia | Q71649480 | ||
| An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis | Q71690263 | ||
| Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli | Q71919139 | ||
| Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome | Q72422330 | ||
| Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor | Q72602383 | ||
| Endothelial vasoactive mediators in preeclampsia | Q72836732 | ||
| Role for endothelin-1 in angiotensin II-mediated hypertension | Q73532048 | ||
| Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure | Q73567364 | ||
| Endothelin | Q73652084 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia | Q74195115 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| Angiotensin II hypertension is attenuated in interleukin-6 knockout mice | Q81472565 | ||
| Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies | Q81781257 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Transgenic mice for studies of the renin-angiotensin system in hypertension. | Q35850586 | ||
| Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo | Q35928298 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| Role of the renin-angiotensin system in the pathogenesis of preeclampsia | Q36064478 | ||
| Endothelin antagonism in pulmonary hypertension, heart failure, and beyond | Q36128040 | ||
| Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction | Q36228832 | ||
| The renin-angiotensin-aldosterone system in preeclampsia. A review | Q36453940 | ||
| Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation | Q36468176 | ||
| Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug. | Q36495001 | ||
| Inflammation and pre-eclampsia | Q36530771 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model | Q36891528 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis | Q37169356 | ||
| Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. | Q37365303 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Endothelin receptor antagonists as antihypertensives: the next frontier | Q37511009 | ||
| Etiology and pathogenesis of preeclampsia: current concepts | Q40835002 | ||
| Elevated IL-6 in midtrimester amniotic fluid is involved with the onset of preeclampsia | Q40857999 | ||
| Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia | Q44141134 | ||
| Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation | Q44302005 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia | Q44809422 | ||
| Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats | Q44895722 | ||
| Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation | Q45020438 | ||
| Potential role of endothelin-1 in normal and hypertensive pregnancies | Q46165905 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects | Q46368521 | ||
| Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells | Q46594619 | ||
| Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension | Q46819084 | ||
| Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion | Q46877931 | ||
| Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies | Q46878600 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| State-of-the-Art lecture. Role of endothelin-1 in hypertension | Q48581888 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. | Q51436935 | ||
| Increased expression of interleukin 6 in term compared to the first trimester human placental villi. | Q52167315 | ||
| Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia | Q52995596 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2 | Q60539322 | ||
| Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide | Q60585302 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| autoantibody | Q785022 | ||
| P304 | page(s) | 6024-6034 | |
| P577 | publication date | 2011-04-11 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | |
| P478 | volume | 186 |
| Q27003069 | A leading role for the immune system in the pathophysiology of preeclampsia |
| Q36328239 | Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q26828588 | Antibodies in the pathogenesis of hypertension |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q35953472 | Blocking Endogenous Leukemia Inhibitory Factor During Placental Development in Mice Leads to Abnormal Placentation and Pregnancy Loss |
| Q45020552 | Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia |
| Q92759792 | Effect of a black cumin (Nigella sativa) ethanol extract on placental angiotensin II type 1-receptor autoantibody (AT1-AA) serum levels and endothelin-1 (ET-1) expression in a preeclampsia mouse model |
| Q36099171 | Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus |
| Q26852668 | Elucidating immune mechanisms causing hypertension during pregnancy |
| Q36902613 | Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females |
| Q36351174 | Four Pathways Involving Innate Immunity in the Pathogenesis of Preeclampsia |
| Q36380039 | GPCRs as potential therapeutic targets in preeclampsia. |
| Q36712010 | Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta |
| Q37306127 | Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats |
| Q35853182 | Hypoxia-Mediated Soluble Fms-Like Tyrosine Kinase 1 Increase Is Not Attenuated in Interleukin 6-Deficient Mice |
| Q36417912 | IL-6 Trans-Signaling Drives Murine Crescentic GN |
| Q53433801 | Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients. |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q27007059 | Is inflammation the cause of pre-eclampsia? |
| Q38543831 | Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia? |
| Q36190273 | New frontiers in heart hypertrophy during pregnancy. |
| Q48523077 | Preeclampsia: From Inflammation to Immunoregulation |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q39136791 | Recent Advances in Immunity and Hypertension |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q57254079 | Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia |
| Q47153840 | Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction |
| Q52594781 | The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia. |
| Q37729072 | The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia |
| Q38693025 | The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia |
| Q38014802 | The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms |
| Q33834419 | The role of inflammation in the pathology of preeclampsia |
| Q44770951 | Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation |
| Q47693328 | Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes |
| Q38116097 | Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q36659088 | Uterine Regulatory T cells, IL-10 and hypertension |
| Q36699839 | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia |
Search more.